Against panel's advice, Israel Health Ministry chooses cheap cervical cancer vaccine
The ministry's tender committee gave the contract to GlaxoSmithKline's Cervarix vaccine because GSK's price was 10 percent lower than the bid submitted by MSD, maker of the rival vaccine Gardasil.
The Health Ministry recently awarded a tender for the purchase of cervical cancer vaccine that contradicted the recommendation of an expert committee.
register with haaretz
Like us on Facebook and get articles directly in your news feed